{"title":"先天性鱼鳞病与皮肤恶性肿瘤相关的病例对照研究","authors":"Kaya L. Curtis, Steven Zeldin, Shari R. Lipner","doi":"10.1007/s00403-025-04259-y","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Congenital ichthyoses are a heterogeneous group of keratinization disorders. Though there are case reports describing skin cancer development in congenital ichthyosis patients, the risk of skin cancer in congenital ichthyosis patients compared to the general population is unknown.</p><h3>Objective</h3><p>We aimed to evaluate the association of congenital ichthyosis with cutaneous malignancies using a large national database.</p><h3>Methods</h3><p>A nested case-control study using the National Institutes of Health <i>All of Us</i> database was conducted analyzing participants ≥ 18 years with CI and controls matched 1:12 by age, sex, and race/ethnicity. Multivariate logistic regression assessed odds ratios for CI and skin cancer associations (<i>P</i> < 0.05).</p><h3>Key results</h3><p>A total of 198 CI participants and 2,376 controls were included in the final analysis. Mean age of CI participants was 67.2 years, with 56.1% female and 67.7% white, similar to controls (<i>P</i> = 0.97, <i>P</i> = 1, <i>P</i> = 0.99, respectively). After controlling for smoking, alcohol, obesity, and mobility, congenital ichthyosis was associated with actinic keratosis (AK) (OR = 3.65; 95% CI 1.00-5.51; <i>P</i> < 0.001), melanoma (OR = 2.39; 95% CI 1.05–5.45; <i>P</i> = 0.04), and basal cell carcinoma (BCC) (OR = 1.90; 95% CI 1.03–3.39; <i>P</i> = 0.03), but not squamous cell carcinoma (SCC) (<i>P</i> = 0.50).</p><h3>Conclusion</h3><p>We found that CI was associated with cutaneous malignancies. Larger scale studies are needed to confirm these findings with narrower confidence intervals. We recommend routine skin cancer surveillance in CI patients pending additional studies clarifying risk of cutaneous malignancy.</p></div>","PeriodicalId":8203,"journal":{"name":"Archives of Dermatological Research","volume":"317 1","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Congenital ichthyosis is associated with cutaneous malignancies in a case-control study\",\"authors\":\"Kaya L. Curtis, Steven Zeldin, Shari R. Lipner\",\"doi\":\"10.1007/s00403-025-04259-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Congenital ichthyoses are a heterogeneous group of keratinization disorders. Though there are case reports describing skin cancer development in congenital ichthyosis patients, the risk of skin cancer in congenital ichthyosis patients compared to the general population is unknown.</p><h3>Objective</h3><p>We aimed to evaluate the association of congenital ichthyosis with cutaneous malignancies using a large national database.</p><h3>Methods</h3><p>A nested case-control study using the National Institutes of Health <i>All of Us</i> database was conducted analyzing participants ≥ 18 years with CI and controls matched 1:12 by age, sex, and race/ethnicity. Multivariate logistic regression assessed odds ratios for CI and skin cancer associations (<i>P</i> < 0.05).</p><h3>Key results</h3><p>A total of 198 CI participants and 2,376 controls were included in the final analysis. Mean age of CI participants was 67.2 years, with 56.1% female and 67.7% white, similar to controls (<i>P</i> = 0.97, <i>P</i> = 1, <i>P</i> = 0.99, respectively). After controlling for smoking, alcohol, obesity, and mobility, congenital ichthyosis was associated with actinic keratosis (AK) (OR = 3.65; 95% CI 1.00-5.51; <i>P</i> < 0.001), melanoma (OR = 2.39; 95% CI 1.05–5.45; <i>P</i> = 0.04), and basal cell carcinoma (BCC) (OR = 1.90; 95% CI 1.03–3.39; <i>P</i> = 0.03), but not squamous cell carcinoma (SCC) (<i>P</i> = 0.50).</p><h3>Conclusion</h3><p>We found that CI was associated with cutaneous malignancies. Larger scale studies are needed to confirm these findings with narrower confidence intervals. We recommend routine skin cancer surveillance in CI patients pending additional studies clarifying risk of cutaneous malignancy.</p></div>\",\"PeriodicalId\":8203,\"journal\":{\"name\":\"Archives of Dermatological Research\",\"volume\":\"317 1\",\"pages\":\"\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-05-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Dermatological Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00403-025-04259-y\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Dermatological Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00403-025-04259-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:先天性鱼鳞病是一种异质性的角化疾病。虽然有病例报告描述了先天性鱼鳞病患者的皮肤癌发展,但先天性鱼鳞病患者与一般人群相比患皮肤癌的风险尚不清楚。目的:利用大型国家数据库,评估先天性鱼鳞病与皮肤恶性肿瘤的关系。方法采用美国国立卫生研究院All of Us数据库进行巢式病例对照研究,对年龄、性别和种族/民族CI匹配为1:12的≥18岁的参与者和对照组进行分析。多因素logistic回归评估CI与皮肤癌关联的比值比(P < 0.05)。最终分析共纳入198名CI参与者和2376名对照。CI参与者的平均年龄为67.2岁,56.1%为女性,67.7%为白人,与对照组相似(P = 0.97, P = 1, P = 0.99)。在控制吸烟、酒精、肥胖和运动后,先天性鱼鳞病与光化性角化病(AK)相关(OR = 3.65;95% ci 1.00-5.51;P < 0.001),黑色素瘤(OR = 2.39;95% ci 1.05-5.45;P = 0.04),基底细胞癌(BCC) (OR = 1.90;95% ci 1.03-3.39;P = 0.03),而鳞状细胞癌(SCC)无统计学意义(P = 0.50)。结论CI与皮肤恶性肿瘤有关。需要更大规模的研究以更窄的置信区间来证实这些发现。我们建议在进一步研究明确皮肤恶性肿瘤风险之前,对CI患者进行常规皮肤癌监测。
Congenital ichthyosis is associated with cutaneous malignancies in a case-control study
Background
Congenital ichthyoses are a heterogeneous group of keratinization disorders. Though there are case reports describing skin cancer development in congenital ichthyosis patients, the risk of skin cancer in congenital ichthyosis patients compared to the general population is unknown.
Objective
We aimed to evaluate the association of congenital ichthyosis with cutaneous malignancies using a large national database.
Methods
A nested case-control study using the National Institutes of Health All of Us database was conducted analyzing participants ≥ 18 years with CI and controls matched 1:12 by age, sex, and race/ethnicity. Multivariate logistic regression assessed odds ratios for CI and skin cancer associations (P < 0.05).
Key results
A total of 198 CI participants and 2,376 controls were included in the final analysis. Mean age of CI participants was 67.2 years, with 56.1% female and 67.7% white, similar to controls (P = 0.97, P = 1, P = 0.99, respectively). After controlling for smoking, alcohol, obesity, and mobility, congenital ichthyosis was associated with actinic keratosis (AK) (OR = 3.65; 95% CI 1.00-5.51; P < 0.001), melanoma (OR = 2.39; 95% CI 1.05–5.45; P = 0.04), and basal cell carcinoma (BCC) (OR = 1.90; 95% CI 1.03–3.39; P = 0.03), but not squamous cell carcinoma (SCC) (P = 0.50).
Conclusion
We found that CI was associated with cutaneous malignancies. Larger scale studies are needed to confirm these findings with narrower confidence intervals. We recommend routine skin cancer surveillance in CI patients pending additional studies clarifying risk of cutaneous malignancy.
期刊介绍:
Archives of Dermatological Research is a highly rated international journal that publishes original contributions in the field of experimental dermatology, including papers on biochemistry, morphology and immunology of the skin. The journal is among the few not related to dermatological associations or belonging to respective societies which guarantees complete independence. This English-language journal also offers a platform for review articles in areas of interest for dermatologists and for publication of innovative clinical trials.